With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
Discover
Related topics
Intoducing cellenONE: The revolutionary Single Cell isolator
May 25, 2022
A revolutionary platform based on sciDROP PICO precision dispensing technology and coupled with advanced image...
May 4, 2022
A prodigy incorporating a unique combination of patent-pending innovative technologies that takes flow cytometry to the...
Introducing Celloger Mini Plus: Automated and compact Live cell imaging inside your incubator
Apr 11, 2022
We are happy to introduce new Celloger Mini Plus, automated live cell imaging system! Click the video below to find out...
CQ1 live-cell confocal system: revealing the pathophysiology of COVID-19 infection
Mar 21, 2022
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities...
Introducing IsoPlexis Single-Cell Natural Killer Panel
Mar 4, 2022
Because of their ability to kill tumour cells, NK cells are an attractive target in cancer immunotherapy, therapeutic...
Enhanced small particle detection on CytekAurora and Northern Lights
Mar 2, 2022
Aurora system with ESP option, can fully resolve particles around 70nm and from the 80nm PS bead. The new violet laser...
Aurora CS spectral sorter - 28 Color in-depth purity sorting
Jan 28, 2022
To demonstrate the Cytek Aurora CS’s capabilities made possible by its advanced electronics design, a 28-color human...
Download today your IsoPlexis e-book: understanding immune Cell Function In Cancer
Dec 1, 2021
Understanding complex immune-cancer interactions is critical to identifying therapeutic targets, devising novel avenues...
IsoPlexis technology: accelerating decisions in immunotherapy with predictive single-cell response
Nov 26, 2021
The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...
Customer Story: Automation at DKMS LIFE SCIENCE LAB
Nov 25, 2021
How DKMS LIFE SCIENCE LAB is Supporting the Fight against Leukemia with New Processes and Automation
Apr 11, 2016
Fluxion Biosciences announced that it has launched its BioFlux Extended Flow module for live cell analysis. The module consists of a new 6-well plate consumable and interface; it is now available and shipping to customers.
BioFlux provides the ability to emulate physiological flow and shear forces in an in vitro model, while maintaining a convenient well plate format. The system enables a multitude of assays that require precise control of the cellular micro-environment, including control of shear forces, liquid composition, gas, and temperature. BioFlux is widely used in basic research and drug development around the world by hundreds of recognized industry leaders (Pfizer, Amgen, BMS, Merck, Bayer), government labs (NIH, Walter Reed Research Center, VA Medical Center) and leading research institutions (Harvard, UC San Francisco, U. Michigan, U. Pennsylvania, Yale, and Oxford).
According to Dr. Bryan Haines, Global Product Director, “BioFlux extended flow plates were developed to address a frequent request of our customers: the need to remove flow time limitations from their assays. The new consumable and 6-well interface accomplish that, while continuing to integrate seamlessly into existing experimental protocols. Using the BioFlux Quattro Array, 12 experiments can be performed over extended time periods of up to 21 days.”
The Extended Flow Module, including consumables and a 6-well interface, is targeted at applications where longer cell or microbial growth under flow conditions is required. The new consumable extends the flow time significantly, from 31 hours using BioFlux 24-well plates at a shear of 1 dyn/cm2, to 110 hours at the same shear using the new extended flow plates. At low flow rates (0.15 dyn/cm2), BioFlux channels can now be kept under perfusion for up to 21 days. Long perfusion times are important for applications such as tuberculosis and urinary tract infection research.
“The introduction of the BioFlux Extended Flow Module provides great validation of our new rapid design-to-product development process. In addition to this new plate type, this process is being used to provide a cost-effective path for the production of customer-specific designs and will enable a much faster response time to develop new capabilities for the BioFlux system,” said Cristian Ionescu-Zanetti, CTO of Fluxion. “With its unique capability to mimic conditions in the body, now for much longer periods of time, the Extended Flow Module is a significant advance that provides for a new class of experiments using the BioFlux system.”
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com